ImmuPharma PLC Long-term Investment Intensity
ImmuPharma PLC long-term investment intensity. ImmuPharma PLC (IMM) has a Long-term Investment Intensity of 25.0% as of June 2019. Long-term investments of GBX2.00 Million represent 25.0% of total assets of GBX8.00 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read ImmuPharma PLC (IMM) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of ImmuPharma PLC (2018–2018)
Long-term investment intensity of ImmuPharma PLC from 2018 to 2018. This chart shows how ImmuPharma PLC's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 25.0%, reflecting long-term investments of GBX2.00 Million against total assets of GBX8.00 Million GBX.
ImmuPharma PLC Long-term Investment Intensity by Year (2018–2018)
ImmuPharma PLC long-term investment intensity by year from 2018 to 2018. The table below presents the year-by-year Long-term Investment Intensity for ImmuPharma PLC from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IMM total assets.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 23.1% | GBX2.00 Million | GBX8.66 Million | — |